產(chǎn)品詳情介紹
本產(chǎn)品含有反轉(zhuǎn)錄反應(yīng)所需的全部試劑(TransScript? RT, RNase Inhibitor, Anchored Oligo(dT)18 Primer,Random Primer(N9), dNTPs, Buffer)，濃度為5×。反應(yīng)時(shí)，只需加入模板RNA和水即可高效合成第一鏈cDNA。操作簡便，降低操作過程中的污染機(jī)率。cDNA 用于常規(guī)PCR，不推薦用于qPCR。
使用前請(qǐng)將各組分點(diǎn)甩離心
1 Deng P, Wang Z, Chen J, et al. RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer[J]. The Journal of Clinical Investigation, 2022.(IF 19.45)
2 Wu Z, Liu D, Pan D, et al. Structure and engineering of miniature Acidibacillus sulfuroxidans Cas12f1[J]. Nature Catalysis, 2023.(IF 37.80)
3 Liu S, Zou Q, Chen J P, et al. Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancer[J]. The Journal of Clinical Investigation, 2021.(IF 19.45)
4 Wang D, Zhang Y, Xu X, et al. YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3[J]. Nature communications, 2021.(IF 12.12)
5 Liu L, Liu S, Deng P, et al. Targeting the IRAK1–S100A9 Axis Overcomes Resistance to Paclitaxel in Nasopharyngeal Carcinoma[J]. Cancer Research, 2021.(IF 12.70)
